Skip to main content

Advertisement

Table 2 HIV-1 Drug Resistance Associated Mutations (DRAMs) in the study participants

From: Emergence of HIV-1 drug resistance mutations in mothers on treatment with a history of prophylaxis in Ghana

Participant groups Reverse transcriptase DRAMs
NRTIs NNRTIs
Art after prophylaxis (Group 1) M184 V K103 N,Y181C
M41 L,M184 V, T215Y K103 N,M230 L,A98G,
M41 L,M184 V,T215Y K103 N A98G,
M41 L,M184 V,T215Y A98G, K103 N
M41 L,M184MV,T215Y A98G,K103 N,M230 LM
M41 L,M184MV,T215Y A98G,K103 N,M230 LM
M41 L,L74 V,T215Y K103 N, A98G,L100IL,,M230 L
K219KR G190EG
Drug naïve group (Group 2) V75S E138A
NONE A98G
M184 V K103 N
L210 W V106A
Art without prophylaxiS (Group 3) M184 V,Y115F,T215S A98G
M41 LM,D67G,K70R,K219E,T215I,M184 V A98G
M184 V NONE
  1. DRAMS Drug Resistance-Associated Mutations to Reverse Transcriptase Inhibitors